Clinical Trials Logo

Clinical Trial Summary

A randomized, double-blind, placebo-controlled, multi-center, phase 2 clinical study in patients with NSTEMI undergoing urgent coronary angiography. Approximately 220 patients with CKD and acute NSTEMI, who are scheduled for an urgent coronary angiography (within 72 hours after admission and/or diagnosis of NSTEMI).


Clinical Trial Description

Approximately 220 patients with chronic kidney disease (CKD) and acute NSTEMI, who are scheduled for an urgent coronary angiography (within 72 hours after admission and/or diagnosis of NSTEMI) will be screened for the study. Only patients with acute NSTEMI presumed to be a spontaneous myocardial infarction, related to atherosclerotic plaque rupture, ulceration, fissuring, erosion, or dissection (i.e. type 1) are eligible. Written informed consent will be obtained before urgent coronary angiography. Patients with NSTEMI will typically undergo coronary angiography within 72 hours after admission and/or diagnosis of NSTEMI. It is estimated that 70% of these patients will have PCI. Randomization will continue until the 160th patient has had a PCI. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04912141
Study type Interventional
Source Pharming Technologies B.V.
Contact
Status Terminated
Phase Phase 2
Start date April 21, 2021
Completion date April 28, 2023

See also
  Status Clinical Trial Phase
Completed NCT03606330 - Systemic, Pancoronary and Local Coronary Vulnerability
Completed NCT04223986 - Prehospital Risk Stratification in Acute Coronary Syndromes N/A
Recruiting NCT03405207 - Vitamin D Deficiency Treatment Outcomes After Non-ST-Segment Elevation Myocardial Infarction Phase 2
Recruiting NCT03863327 - EKG Criteria and Identification of Acute Coronary Occlusion
Active, not recruiting NCT01864031 - The Role of Alcohol Consumption in the Aetiology of Different Cardiovascular Disease Phenotypes: a CALIBER Study N/A
Recruiting NCT03621111 - A Trial on the Role of Community Pharmacist in Improving Adherence and Clinical Outcomes in Post-Infarction N/A
Completed NCT03390270 - Risk-score Based ICU Triage
Recruiting NCT03778554 - Danish Trial of Beta Blocker Treatment After Myocardial Infarction Without Reduced Ejection Fraction Phase 4
Recruiting NCT05751057 - The Role of Cardiovascular Magnetic Resonance in Patients With Non-ST- Elevation- Myocardial Infarction N/A
Recruiting NCT04788186 - Beta Blocker De-prescription Following Coronary Artery Bypass Graft Surgery (BEEFBURGER Trial). Phase 4
Terminated NCT03048019 - Antiplatelet Effects of Tirofiban vs. Cangrelor N-STEMI Patients Undergoing Percutaneous Coronary Intervention
Recruiting NCT02126202 - Coronary Angioplasty in Octogenarians With Emergent Coronary Syndromes Phase 4